Roger B. Cohen
Oncology
3400 Civic Center Boulevard
West Pavilion, 2nd Floor
Philadelphia, PA 19104
West Pavilion, 2nd Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 200 publications
EMBER-Lung: Electronic Medical Record Boosting Molecular Testing in Early-Stage Non-Small Cell Lung Cancer.
Journal: JCO precision oncology
Published: July 15, 2026
Erratum to "The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing" [J. Liq. Biopsy 12 (2026) 100461].
Journal: The journal of liquid biopsy
Published: June 29, 2026
Poor Performance Status Associated With Inferior Tarlatamab Outcomes in a Large, Multi-institution Real-World Database of Patients With 2L + ES-SCLC.
Journal: Clinical lung cancer
Published: May 19, 2026
The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing.
Journal: The journal of liquid biopsy
Published: February 08, 2026
Clinicogenomic Features and Outcomes of Adenoid Cystic Carcinoma With Central Nervous System Metastases: A Single-Institution Cohort Study.
Journal: Head & neck
Published: February 01, 2026
Carboplatin plus pemetrexed versus pemetrexed alone in advanced thymoma and thymic carcinoma: a retrospective cohort study.
Journal: Frontiers in oncology
Published: January 25, 2026
Long-Term Results of a Phase 2 Clinical Trial of Radiation Volume and Dose Deintensification Following Transoral Robotic Surgery and Neck Dissection for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: November 15, 2025
Recurrent/metastatic relapse after definitive treatment for HNSCC: timing, patterns, and survival.
Journal: Frontiers in oncology
Published: November 03, 2025
Cardiac substructure radiotherapy dose and changes in physical activity and quality of life after chemoradiotherapy for NSCLC: a secondary analysis of the CLARITY prospective study.
Journal: Clinical and translational radiation oncology
Published: September 02, 2025
Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 04, 2025
A Text Message Intervention to Minimize the Time Burden of Cancer Care.
Journal: NEJM catalyst innovations in care delivery
Published: July 22, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy.
Journal: American journal of clinical oncology
Published: May 25, 2025
Last Updated: 09/26/2026